Nuvalent (NUVL) Change in Accured Expenses (2020 - 2026)

Nuvalent (NUVL) posted Change in Accured Expenses of -$2.1 million for Q1 2026, up 65.79% on a QoQ basis from -$6.2 million in Q4 2025, and down 471.85% year-over-year from $573618.6 in Q1 2025.

Nuvalent (NUVL) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Nuvalent's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 471.85% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 66.02% YoY) and the FY2025 annual result came in at $11.5 million, down 57.34% from the prior year.
  • Change in Accured Expenses was -$2.1 million for Q1 2026 at Nuvalent, up from -$6.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $13.7 million in Q4 2024 and bottomed at -$6.2 million in Q4 2025.
  • A 5-year average of $3.0 million and a median of $2.5 million in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses jumped 5382.35% — and 2026, when it tumbled 471.85%.
  • Nuvalent's Change in Accured Expenses stood at $4.5 million in 2022, then dropped by 14.03% to $3.8 million in 2023, then jumped by 257.18% to $13.7 million in 2024, then sank by 145.35% to -$6.2 million in 2025, then soared by 65.79% to -$2.1 million in 2026.
  • Business Quant data shows NUVL's Change in Accured Expenses at -$2.1 million in Q1 2026, -$6.2 million in Q4 2025, and $5.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,019.86 Bn 66,019.58 Bn - 1.13 Mn
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 931,000.00
4 BeOne Medicines 468.20 Bn 463.41 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.50 Bn 115.26 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.15 Bn 61.39 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 55.58 Bn 50.39 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.43 Bn 34.43 Bn 959.66 Mn -176.03 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - -2.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.13 Mn
Mar 31, 2026 -2.13 Mn
Dec 31, 2025 -6.24 Mn
Dec 31, 2025 -6.24 Mn
Sep 30, 2025 5.23 Mn
Sep 30, 2025 5.23 Mn
Jun 30, 2025 12.84 Mn
Jun 30, 2025 12.84 Mn
Mar 31, 2025 -373,000.00
Mar 31, 2025 -373,000.00
Dec 31, 2024 13.75 Mn
Dec 31, 2024 13.75 Mn
Sep 30, 2024 4.25 Mn
Sep 30, 2024 4.25 Mn
Jun 30, 2024 10.91 Mn
Jun 30, 2024 10.91 Mn
Mar 31, 2024 -2.05 Mn
Mar 31, 2024 -2.05 Mn
Dec 31, 2023 3.85 Mn
Dec 31, 2023 3.85 Mn